首页 > 《中国癌症研究：英文版》 > 1999年1期 > VINDESINE WITH CYCLOPHOSPHAMIDE-EPIRUIBIN-CISPLATININ THE TREATMENT LOCALLY ADVANCED NON-SMALCELL LUNG CANCER

VINDESINE WITH CYCLOPHOSPHAMIDE-EPIRUIBIN-CISPLATININ THE TREATMENT LOCALLY ADVANCED NON-SMALCELL LUNG CANCER

在线阅读下载PDF 导出详情

摘要 Lungcancerrepresentstheleadingcauseofcancerdeathsinhuman.Non-smallcelllungcancer(NSCLC)accountsforabout75%--85%ofalllungcancersandcanbesurgicallyresectedinonly30%--40%ofpatientswithlimiteddisease.[1’21Theremainingpatients,withlocallyadvancedormetasta...

DOI ojnpqk1l4r/708985

作者胡艳萍;柯玉华;付小玉

机构地区不详

出处《中国癌症研究：英文版》 1999年1期

关键词 CHEMOTHERAPY LOCALLY advanced NSCLC.

分类 [医药卫生][肿瘤]

出版日期 1999年01月11日（中国期刊网平台首次上网日期，不代表论文的发表时间）

相关文献

1Jean G. Bustamante Alvarez;Maria Gonzalez-Cao;Niki Karachaliou;Mariacarmela Santarpia;Santiago Viteri;Cristina Teixido;Rafael Rosell. Advances in immunotherapy for treatment of lung cancer.肿瘤,2015-03.
2Xu Yang,Chen Liang-An. Lung cancer treatment in the era of immunotherapy.医药卫生,2020-11.
3Siyuan Ren,Mengyao Ma,Chuan He,Yuhui Deng,Xiaoyun Chen,Yonglin Liu,Yangyang Jin,Yansong Liu,Lei Cai,Lin He. Placebo effect in the treatment of non-small cell lung cancer: a meta-analysis.医药卫生,2022-12.
4Phillip J Gray;Jason A Efstathiou;William U Shipley. The opportunity cost of androgen suppression in locally advanced prostate cancer.泌尿科学,2013-03.
5LianChen;RuiChen;ZheZhu;YichenZhang;ZhengweiWen;YunLi;XiaomingLi;YuwenLuo;LiyuMa;ShuguangLin;XinChen. Predictive factors associated with gefitinib response in patients with advanced non-small-cell lung cancer （NSCLC）.肿瘤,2014-04.
6张集昌;张力健;张晓东;王燕蒙;李伟. THE MALIGNANT OBSTRUCTION OF THE ESOPHOGAS BY ADVANCED CANCER AND RELIEVED BY ENDOSCOPIC TREATMENT.肿瘤,1999-03.
7MiSunKim;JoonSeokLim;WooJinHyung;YongChanLee;SunYoungRha;KiChangKeum;WoongSubKoom. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.消化系统,2015-09.
8Xiaosong Chen;Guolin Ye;Chenfang Zhang;Xinzheng Li;Kunwei Shen. Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients.肿瘤,2016-06.
9Olga B. Garbuzenko;Gediminas Mainelis;Oleh Taratula;Tamara Minko. Inhalation treatment of lung cancer： the influence of composition, size and shape of nanocarriers on their lung accumulation and retention.肿瘤,2014-01.
10Zhou Fei,Zhou Cai-Cun. Immunotherapy in non-small cell lung cancer: advancements and challenges.医药卫生,2021-05.

来源期刊

中国癌症研究：英文版

中国癌症研究：英文版

相关推荐

同分类资源更多

相关关键词

CHEMOTHERAPY LOCALLY advanced NSCLC.

返回顶部